Answer
Avalglucosidase alfa (Nexviadyme) requires caution because infusion may seriously worsen cardiac or respiratory status in patients susceptible to fluid overload or with compromised function requiring fluid restriction, so medical support and monitoring should be readily available and some patients may need prolonged observation.
Sources for this answer
- Nexviadyme 100 mg powder for concentrate for solution for infusionSANOFI · emc · SmPC §4.4 Special warnings and precautions for use · Version 4Document updated
Sources checked